B

Bright Minds Biosciences Inc
CNSX:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
CNSX:DRUG
Watchlist
Price: 59 CAD 4.8% Market Closed
Market Cap: 263.4m CAD
Have any thoughts about
Bright Minds Biosciences Inc?
Write Note

Bright Minds Biosciences Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bright Minds Biosciences Inc
Revenue Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Bright Minds Biosciences Inc
CNSX:DRUG
Revenue
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Revenue
$84.3m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
33%
Repare Therapeutics Inc
NASDAQ:RPTX
Revenue
$51.1m
CAGR 3-Years
700%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Revenue
$207.1m
CAGR 3-Years
53%
CAGR 5-Years
238%
CAGR 10-Years
72%
Covalon Technologies Ltd
XTSX:COV
Revenue
CA$29.2m
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
12%
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.9m
CAGR 3-Years
-6%
CAGR 5-Years
-14%
CAGR 10-Years
-4%

See Also

What is Bright Minds Biosciences Inc's Revenue?
Revenue
0 CAD

Based on the financial report for Sep 30, 2023, Bright Minds Biosciences Inc's Revenue amounts to 0 CAD.

Back to Top